Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, Adjusted Operating Income, and Adjusted EBITDA, with currency-neutral net sales increasing by 4% year-over-year [4][14] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales in the Americas increasing by 5.5% and in EAAA by 2.4% [21][22] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and nora Rubber) experienced growth in both price and volume [5] - Global rubber billings increased by 17% in 2025 compared to the prior year [6] - Healthcare billings were up 21% year-over-year, while education billings increased by 8% [14][15] Market Data and Key Metrics Changes - In the Americas, currency-neutral net sales increased by 5% year-over-year, particularly strong in healthcare and education segments [14] - EAAA region saw a 2% increase in currency-neutral net sales, reflecting improving trends despite a challenging macro environment [14] - Corporate office billings were slightly up, with a focus on Class A spaces [15] Company Strategy and Development Direction - The company is committed to the "One Interface" strategy, focusing on global functions to support local selling teams and enhancing commercial productivity [4] - Continued investments in automation and robotics are expected to drive productivity gains and margin expansion [7][8] - The launch of Noravant, a new rubber flooring innovation, aims to expand the addressable market in the resilient category [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth driven by strong demand in healthcare and education, supported by macro tailwinds [15][16] - For 2026, the company expects net sales of $1.42 billion to $1.46 billion, with an adjusted gross profit margin of approximately 38.5%-39% [28][29] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [24] - Capital expenditures for 2025 were $46.2 million, with an expected increase to $55 million in 2026 to support automation initiatives [25] - The board approved an increase in the quarterly dividend from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams in the U.S., with healthcare billings up 21% and nora business up 17% [34] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [36][38] Question: How is the corporate market performing compared to healthcare and education? - Management indicated that the corporate business was flat, with retail business being soft, but healthcare and education showed strong growth [46][47] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across initiatives, providing confidence entering 2026 [50][51] Question: How is SG&A being managed while pursuing growth? - Management emphasized disciplined spending and variable compensation tied to revenue, ensuring efficient use of resources [54][55] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs diluted gross profit percentage by around 20 basis points in 2025, with an anticipated 50 basis points impact in 2026 [91] Question: Can you provide global billings by category for Q4? - Management reported that corporate was flat, education was up 11.6%, and healthcare was up 11.7% [105]

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, adjusted operating income, and adjusted EBITDA, marking the highest levels in its history [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [21] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume [5] - Global healthcare billings were up 21% year-over-year, with double-digit gains in the Americas and EAAA [14] - Education billings increased 8% for the full year, reflecting the success of expanded collection offerings [15] - Corporate office billings were up slightly for the year, with a focus on gaining share in Class A spaces [15] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase [21] - The company reported a 2% increase in consolidated currency-neutral orders year-over-year [20] - The healthcare and education sectors are experiencing increased investment, driven by aging populations and modernization efforts [15] Company Strategy and Development Direction - The "One Interface" strategy focuses on building strong global functions to support local selling teams and enhancing commercial productivity [4] - The company is committed to sustainability, with initiatives including the launch of a cradle-to-gate carbon negative rubber prototype [12] - The introduction of the noravant product line is expected to open new design possibilities and expand the addressable market [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth in 2026, with a focus on expanding its addressable market through innovative products and pricing strategies [16] - Management acknowledged ongoing macro uncertainties but highlighted a solid order backlog and healthy growth expectations [27] Other Important Information - The company plans to increase capital expenditures to $55 million in 2026 to support automation and productivity initiatives [25] - A quarterly dividend increase from $0.02 to $0.03 per share was approved, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams, with healthcare billings up 21% and expectations for continued growth through the launch of noravant [35][36] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [38][39] Question: What is the outlook for the corporate market? - Management indicated that the corporate market remains competitive, with growth expectations aligned with strong demand in Class A spaces [48] Question: Can you elaborate on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for entering 2026 [51][53] Question: How is the company managing SG&A expenses? - Management emphasized a disciplined approach to SG&A, focusing on investments that drive growth while maintaining efficiency [56][57] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for modest inflation in raw materials [95][96]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with net sales, Adjusted Operating Income, and Adjusted EBITDA reaching their highest levels in history, driven by the One Interface strategy [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [18] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [19] - Adjusted EPS was $1.94, a 33% increase compared to $1.46 [20] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume, with global rubber billings up 17% in 2025 [5][12] - Healthcare billings were up 21% year-over-year, while education billings increased 8% [12][13] - Corporate office billings were up slightly, reflecting a competitive market environment [14] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase, indicating improving trends in international markets [18] - The healthcare sector is experiencing increased investment due to aging populations and a focus on preventative care, benefiting the company [13] - The corporate market remains competitive, with Class A spaces in demand, particularly in major cities like New York and San Francisco [44][64] Company Strategy and Development Direction - The One Interface strategy focuses on building strong global functions to support local selling teams, enhancing commercial productivity, and expanding margins through supply chain management [4] - The company is committed to sustainability, with a focus on low-carbon products and innovative solutions like the new Noravant rubber flooring [11][9] - Future growth will be driven by expanding addressable markets through innovative product offerings and maintaining a disciplined approach to SG&A expenses [15][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education markets [6] - The company anticipates continued growth in 2026, with a focus on leveraging successful strategies and expanding product offerings [14][24] - Management acknowledged ongoing macro uncertainties but remains optimistic about solid orders and a healthy backlog entering 2026 [24] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [21] - Capital expenditures were $46.2 million in 2025, with expectations to increase to $55 million in 2026 to support automation and productivity initiatives [22] - The quarterly dividend was increased from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [23] Q&A Session Summary Question: Can you elaborate on the One Interface selling strategy? - Management highlighted the success of the combined selling teams and the potential for further expansion in healthcare and education markets [29][30] Question: What are the expectations for gross margins in 2026? - Management indicated that gross margins are expected to continue improving, driven by automation and efficiency initiatives [33][34] Question: How is the corporate market performing compared to healthcare and education? - Management noted that while corporate business was flat, healthcare and education saw significant growth, with ongoing demand in Class A spaces [42][44] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for 2026 [47][49] Question: How is SG&A being managed while pursuing growth opportunities? - Management emphasized disciplined spending and a focus on variable compensation tied to revenue, ensuring efficiency [52][56] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for continued monitoring and adjustments [93][94]

分组1 - Interface reported quarterly earnings of $0.49 per share, exceeding the Zacks Consensus Estimate of $0.40 per share, and up from $0.34 per share a year ago, representing an earnings surprise of +22.50% [1] - The company achieved revenues of $349.39 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.27%, and an increase from $335.01 million year-over-year [2] - Interface has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has increased approximately 12.8% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.26 on revenues of $315 million, and for the current fiscal year, it is $2.00 on revenues of $1.44 billion [7] - The Zacks Industry Rank for Textile - Home Furnishing is in the bottom 29% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Interface: A differentiated global flooring leader Purpose-driven growth with disciplined execution 50+ year history INVESTOR UPDATE | FEBRUARY 2026 FORWARD LOOKING STATEMENTS AND NON-GAAP MEASURES This presentation contains forward-looking statements, including, in particular, statements about Interface's plans, strategies and prospects. These are based on the Company's current assumptions, expectations and projections about future events. Although Interface believes that the expectations reflected in thes ...

Financial Performance - Fourth quarter 2025 net sales reached $349 million, a 4.3% increase year-over-year, while full year net sales totaled $1.387 billion, up 5.4%[7] - Adjusted earnings per diluted share for the fourth quarter increased by 44.1% to $0.49, and for the full year, it rose by 32.9% to $1.94[7] - Adjusted operating income for the fourth quarter increased by 16.7% to $38.2 million, and for the full year, it rose by 22.9% to $173.8 million[8] - Net income for the twelve months ended December 28, 2025, was $116,098 thousand, a significant increase of 33.5% compared to $86,946 thousand in 2024[27] - Earnings per share (diluted) for the twelve months ended December 28, 2025, rose to $1.96, up from $1.48 in 2024, reflecting a 32.4% increase[27] - In Q4 2025, the company reported a GAAP net income of $24.4 million, translating to a diluted EPS of $0.41, compared to $21.8 million and $0.37 in Q4 2024, representing a 12% increase in net income year-over-year[34] - For the fiscal year 2025, the company achieved a GAAP net income of $116.1 million with a diluted EPS of $1.96, up from $86.9 million and $1.48 in fiscal year 2024, indicating a 33% increase in net income[36] Profitability Metrics - Adjusted gross profit margin for the fourth quarter improved by 169 basis points year-over-year to 38.6%, driven by favorable pricing and product mix[8] - The company's gross profit for Q4 2025 was $134.8 million, a 10% increase from $122.3 million in Q4 2024, while SG&A expenses rose to $99.4 million from $92.7 million[34] - Non-GAAP Adjusted Operating Income (AOI) for FY 2025 was $173.8 million, up from $141.4 million in FY 2024, representing an increase of 22.8%[41] - Adjusted Earnings before Interest, Taxes, Depreciation, and Amortization (AEBITDA) for FY 2025 was $217.9 million, compared to $189.0 million in FY 2024, indicating a rise of 15.2%[43] Cash Flow and Debt Management - The company generated $49 million in cash from operations and repaid $128 million of debt during the fourth quarter[7] - Total debt decreased by 40% to $181.6 million, while net debt fell by 45.8% to $110.3 million[10] - Cash provided by operating activities for the twelve months ended December 28, 2025, was $167,906 thousand, compared to $148,430 thousand in 2024, marking a 13.2% increase[31] - The company reported a total cash on hand of $71.3 million as of December 28, 2025[45] Sales Growth and Forecast - For fiscal year 2026, the company anticipates net sales between $1.420 billion and $1.460 billion, with an adjusted gross profit margin of 38.5% to 39.0%[15] - Currency-neutral net sales for the fourth quarter increased by 1.6% year-over-year, while full year currency-neutral sales growth was 4.3%[8] - Currency-neutral net sales for the fiscal year 2025 reached $1,371.9 million, up from $1,315.7 million in fiscal year 2024, reflecting a growth of 4.3%[39] - The One Interface strategy contributed to a 21% increase in global billings in the Healthcare segment and an 8% increase in the Education segment for the fiscal year[4] Regional and Segment Performance - Net sales by region for the twelve months ended December 28, 2025, showed that the Americas accounted for 61%, EMEA for 29%, and APAC for 10% of total sales[32] - Corporate/Office vertical contributed 44% to gross billings for the twelve months ended December 28, 2025, followed by Education at 20% and Healthcare at 11%[33] - In Q4 2025, the EAAA segment generated net sales of $143.5 million, while the AMS segment reported $205.9 million, leading to consolidated net sales of $349.4 million[39] Adjustments and Other Financial Impacts - The company incurred $2.9 million in restructuring and other net adjustments in Q4 2025, which positively impacted the adjusted operating income[34] - The impact of currency changes on net sales for fiscal year 2025 was a reduction of $14.9 million, highlighting the importance of currency fluctuations on revenue[39] - The company experienced a loss of $2.3 million related to property casualty in fiscal year 2025, which was accounted for in the financial results[36] - The impact of cyber events on GAAP Operating Income was a loss of $0.3 million in Q4 2024, while there was no impact reported for Q4 2025[41] - Income Tax Expense for Q4 2025 was $2.7 million, down from $5.6 million in Q4 2024, a decrease of 51.8%[43] - Interest Expense for FY 2025 was $19.5 million, a decrease from $23.2 million in FY 2024, reflecting a reduction of 16.0%[43]

Core Viewpoint - Interface, Inc. has announced an increase in its regular quarterly cash dividend from $0.02 to $0.03 per share, reflecting confidence in the business and commitment to shareholder value creation [1] Dividend Announcement - The Board of Directors declared a quarterly cash dividend of $0.03 per share, payable on April 10, 2026, to shareholders of record as of March 27, 2026 [1] - This marks the second dividend increase within the past six months, indicating a focus on disciplined capital allocation [1] Company Overview - Interface, Inc. is recognized as a global leader in flooring and sustainability, with a product portfolio that includes carpet tiles, rubber flooring, and premium area rugs [1] - The company emphasizes innovation that combines design, performance, and sustainability, aiming to become carbon negative by 2040 without the use of offsets [1] Financial Performance - In the fourth quarter of 2025, Interface reported net sales of $349 million, representing a year-over-year increase of 4.3%, and a 1.6% increase on a currency-neutral basis [1] - The company generated $49 million in cash from operations and repaid $128 million of debt during the same period [1]

Core Insights - Interface, Inc. reported a net sales increase of 4.3% year-over-year, totaling $349 million for the fourth quarter [1] - The company achieved GAAP earnings per diluted share of $0.41 and adjusted earnings per diluted share of $0.49 [1] - Cash generated from operations amounted to $49 million, with $128 million of debt repaid during the quarter [1] Financial Performance - Fourth quarter net sales were $349 million, reflecting a 4.3% increase compared to the previous year [1] - On a currency-neutral basis, net sales increased by 1.6% [1] - GAAP earnings per diluted share were reported at $0.41, while adjusted earnings per diluted share were $0.49 [1] Cash Flow and Debt Management - The company generated $49 million in cash from operations during the fourth quarter [1] - A total of $128 million in debt was repaid, indicating a focus on reducing leverage [1]

Core Insights - ONWARD Medical N.V. has successfully implanted its investigational ARC-BCI® Therapy in two additional individuals with spinal cord injuries, bringing the total number of human implants to seven, reinforcing its leadership in brain-computer interface (BCI) technology for restoring movement in paralyzed individuals [1][7] Company Overview - ONWARD Medical is a neurotechnology company focused on developing therapies to restore movement, function, and independence for individuals with spinal cord injuries and other movement disabilities [5] - The company has received 10 Breakthrough Device Designations from the FDA and its ARC EX® System is cleared for commercial sale in the US and Europe [5] - The company is headquartered in the Netherlands, with additional facilities in Switzerland and the US [6] Technology and Research - The ARC-BCI Therapy involves an implant placed epidurally on the motor cortex, which records brain signals related to movement intention and uses AI to decode these signals for spinal cord stimulation [3] - The latest procedures were conducted at the Centre Hospitalier Universitaire Vaudois in Switzerland, involving a 35-year-old woman and a 39-year-old man, aimed at restoring upper- and lower-limb movement, respectively [2] - The ARC-BCI System has been supported by over eight years of human safety data and has received Breakthrough Device Designation from the FDA in 2024 [3] Funding and Support - The ongoing clinical feasibility studies for ARC-BCI Therapy are supported by grants from the European Union's Horizon Europe program, the Christopher & Dana Reeve Foundation, and the Swiss State Secretariat for Education, Research and Innovation [4]

Core Insights - BLAQclouds has launched a redesigned ApolloCASH user interface aimed at simplifying secure cross-border remittance transactions while maintaining institutional-grade security [4][10][17] User Experience Enhancements - The new ApolloCASH interface features a step-by-step Send and Redeem workflow that aligns with modern financial applications, making it user-friendly for individuals regardless of their blockchain knowledge [10][12] - The Send flow allows verified members to select funding methods, enter amounts, and identify recipients using various identifiers, while the Redeem flow notifies recipients of available funds and simplifies the settlement process [12][14] Security and Compliance - ApolloCASH operates on a member-based model requiring active accounts for both senders and receivers, ensuring transaction verification and compliance [15] - The platform employs zero-knowledge verification and maintains a secure transaction receipt without requiring users to manage wallets or private keys [12][14] Integration with Traditional Finance - The updated interface supports multiple funding and payout methods, including PayPal, Venmo, Cash App, Zelle, Wise, and Revolut, facilitating seamless conversion between fiat and blockchain-settled value [16] - Final settlement events are recorded on the Apollo Chain, ensuring transparency and trust while preserving user privacy [16] Strategic Vision - The redesign reflects BLAQclouds' mission to make blockchain infrastructure usable and compliant, empowering users to move value globally with confidence [17][18]